Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sanofi
Payers
Analysts, advocates, pharma outline areas for CMS to improve IRA
Planned updates to the the Medicare Drug Price Negotiation Program need to take its unintended consequences into account, panelists said Tuesday.
Dave Muoio
Nov 8, 2023 4:00pm
GoodRx, Sanofi to offer $35 insulin at 70,000 pharmacies
Oct 20, 2023 7:20am
Federal appeals court hands pharma a win on 340B restrictions
Jan 31, 2023 12:50pm
California sues major PBMs, drugmakers over insulin prices
Jan 13, 2023 3:15pm
Optum, Sanofi team to offer low-cost insulin to uninsured
Aug 2, 2022 7:10am
Merck sues HHS to avoid fine over 340B restrictions
Jul 12, 2022 3:20pm